EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

How we deal with Staphylococcus aureus (MSSA, MRSA) central nervous system infections

Roberta Maria Antonello, Niccolò Riccardi

Frontiers in Bioscience-Scholar · 12.01.2022 · 14 (1)

DOI: 10.31083/j.fbs1401001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Scholar, online erschienen am 12.01.2022. Verfasst von Roberta Maria Antonello und 1 weiteren Autor:innen. Beteiligte Einrichtung: Azienda Sanitaria Universitaria Giuliano Isontina ASUGI, Trieste University Hospital, 34149 Trieste, Italy. Hauptthemen laut MEDLINE: Central Nervous System Infections, Meningitis, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among central nervous system (CNS) infections (e.g., meningitis, brain abscess, ventriculitis, transverse myelitis), those caused by Staphylococcus aureus (SA) are particularly challenging both in management and treatment, with poor clinical outcomes and long hospital stay. It has been estimated that SA is responsible for around 1%–7% of meningitis (up to 19% in healthcare-associated meningitis). Recent neurosurgical procedures and immunocompromisation are major risk factors for SA CNS infections. Hand hygiene, surveillance nasal swabs and perioperative prophylaxis are crucial points for effective SA infections prevention. In case of SA-CNS infections, pending microbiological results, anti-methicillin-resistant SA (MRSA) antibiotic, with good CNS penetration, should be included, with prompt de-escalation as soon as MRSA is ruled out. Consultation with an expert in antimicrobial therapy is recommended as well as prompt source control when feasible. In this narrative review, we reviewed current literature to provide practical suggestions on diagnosis, prevention, management, and treatment of SA CNS infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System InfectionsMeningitisMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsHumansStaphylococcus aureus

Stichwörter der Autor:innen

CNSCentral nervous systemMRSAMSSAManagementReviewStaphylococcus aureus

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Azienda Sanitaria Universitaria Giuliano Isontina ASUGI, Trieste University Hospital, 34149 Trieste, Italy.
  • Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.

Zitieren

APA

Antonello, R. M., & Riccardi, N. (2022). How we deal with Staphylococcus aureus (MSSA, MRSA) central nervous system infections. Frontiers in Bioscience-Scholar, 14(1). https://doi.org/10.31083/j.fbs1401001

Vancouver

Antonello RM, Riccardi N. How we deal with Staphylococcus aureus (MSSA, MRSA) central nervous system infections. Frontiers in Bioscience-Scholar. 2022;14(1). doi:10.31083/j.fbs1401001

BibTeX
@article{Antonello2022,
  author = {Antonello, Roberta Maria and Riccardi, Niccolò},
  title = {How we deal with Staphylococcus aureus (MSSA, MRSA) central nervous system infections},
  journal = {Frontiers in Bioscience-Scholar},
  year = {2022},
  volume = {14},
  number = {1},
  doi = {10.31083/j.fbs1401001}
}
Kostenlos starten →